Alopecia areata was more likely to develop in patients with inflammatory bowel disease (IBD) who were taking anti–tumor necrosis factor (TNF) therapy at the onset of the condition.

60.6% were women; 69.7%, 69.2%, 60.8%, and 68.9% were White; and they had a disease duration since diagnosis of 9.9, 11.6, 8.7, and 8.8 years, respectively. Among patients receiving ritlecitinib, ...

When experts discuss hair loss in women, most point to the typical symptoms and causes. For instance, breakage and thinning ...

In men, it causes a receding hairline and a thinning crown, whereas in women, it causes overall ... and Drug Administration (FDA) for alopecia areata treatment, it can have adverse side effects.

One of the most prevalent dermatological conditions in children is alopecia areata (AA), which is caused by an autoimmune attack on the hair follicles that is mediated by T cells. Youngsters and their ...

While most previously reported cases have described localized hair loss confined to the site of the tick attachment, this particular case presents a notable departure from that pattern, revealing ...

Pfizer’s JAK/TEC inhibitor Litfulo has been recommended for NHS use as a treatment for hair loss caused by severe alopecia areata, the first drug therapy for a condition that affects around ...

Why are we all so scared of it? I’m led to believe that Black women and femmes with alopecia aren’t the only ones affected by the disability. Maybe all Black women, especially those of us who ...

What are Topical Hair Loss Treatments ... and women that can be treated with prescription-grade or over-the-counter hair loss treatments: Male or female pattern hair loss (androgenetic alopecia ...